Advertisement

Central European Journal of Medicine

, Volume 5, Issue 4, pp 475–477 | Cite as

Tuberculous spondylitis in patients with end-stage renal disease undergoing chronic hemodialysis therapy — Report of two cases

Case Report
  • 34 Downloads

Abstract

Tuberculous spondylitis is more common in patients with chronic renal failure who receive hemodialysis because of their abnormal T-cell-mediated immunity. It frequently poses both diagnostic and therapeutic challenges. We describe two cases of tuberculous spondylitis in patients undergoing chronic hemodialysis therapy. They are IFN-γ assay diagnosed (QuantiFERON-TB Gold) and conservatively treated. Our cases suggest that IFN-γ assays equip clinicians with more accurate tools for tuberculosis control. A combination of T-SPOT.TB testing and MRI assessment may be the accurate method to diagnose tuberculous spondylitis in patients with end-stage renal disease.

Keywords

Tuberculous spondylitis End-stage renal disease IFN-γ assay Magnetic resonance imaging Antituberculous treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005, 172, 1169–1227CrossRefGoogle Scholar
  2. [2]
    Chou KJ, Fang HC, Bai KJ, Hwang SJ, Yang WC, Chung HM: Tuberculosis in maintenance dialysis patients. Nephron 2001, 88, 138–143CrossRefPubMedGoogle Scholar
  3. [3]
    Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M: Detecting Latent Tuberculosis Infection in Hemodialysis Patients: A Head-to-Head Comparison of the T-SPOT.TB Test, Tuberculin Skin Test, and an Expert Physician Panel Clin J Am Soc Nephrol 2007, 2, 68–73Google Scholar
  4. [4]
    Poduval RD, Hammes MD: Tuberculosis screening in dialysis patients: Is the tuberculin test effective? Clin Nephrol 2003, 59, 436–440PubMedGoogle Scholar
  5. [5]
    Khalfallah M, Faure A, Hamel O, Cantarovich D, Doe K, Raoul S, Bord E, Robert R: Dialysis-associated spondyloarthropathy. Case report and literature review. Neurochirurgie 2005, 51, 165–172CrossRefPubMedGoogle Scholar
  6. [6]
    Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, Sakhuja V, Jha V: The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005, 20, 2720–2724CrossRefPubMedGoogle Scholar
  7. [7]
    Fang HC, Chou KJ, Chen CL, Lee PT, Chiou YH, Hung SY, Chung HM: Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area. Nephron 2002, 91, 682–687CrossRefPubMedGoogle Scholar
  8. [8]
    Wauters A, Peetermans WE, Van den Brande P, De Moor B, Evenepoel P, Keuleers H, Kuypers D, Stas K, Vanwalleghem J, Vanrenterghem Y, Maes BD: The value of tuberculin skin testing in haemodialysis patients J. Nephrol Dial Transplant 2004, 19, 433–438CrossRefPubMedGoogle Scholar
  9. [9]
    Aggarwal I: Tuberculosis — diagnosis and investigation. Hospital Pharmacist 2006, 13, 73–78Google Scholar
  10. [10]
    Niu CC, Chen WJ, Chen LH, Shih CH: Destructive spondyloarthropathy mimicking spondylitis in long-term hemodialysis patients. Arch Orthop Trauma Surg 2000, 120, 594–597CrossRefPubMedGoogle Scholar
  11. [11]
    Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW: Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007, 175, 618–627CrossRefPubMedGoogle Scholar
  12. [12]
    Pai M, Lewinsohn DM: Interferon gamma assays for tuberculosis. Is anergy the Achilles’ heel? Am J Respir Crit Care Med 2005, 172, 519–521CrossRefPubMedGoogle Scholar
  13. [13]
    Brock I, Munk ME, Kok-Jensen A, Andersen P: Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001, 5, 462–467PubMedGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Departments of NeurologyMinistry of InteriorSofiaBulgaria
  2. 2.Nephrology of Medical InstituteMinistry of InteriorSofiaBulgaria

Personalised recommendations